Larysa Mykhalska

Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma.

R. Greil, J. Burke, G. Salles, 2021, The New England journal of medicine.

The POLARIX Study: Polatuzumab Vedotin with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

R. Greil, J. Burke, G. Salles, 2021, Blood.

Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

R. Greil, J. Burke, G. Salles, 2021, New England Journal of Medicine.